June 26, 2017 1:55 AM ET

Healthcare Equipment and Supplies

Company Overview of Velano Vascular, Inc.

Company Overview

Velano Vascular, Inc., a medical device company, manufactures needle-free vascular access devices for drawing blood. It offers Pivo, a single-use disposable device to take blood samples from indwelling peripheral IV lines to reduce the amount of needle sticks and central line access for blood collection. The company was incorporated in 2011 and is based in San Francisco, California.

3138 Geary Boulevard

San Francisco, CA 94118

United States

Founded in 2011



Key Executives for Velano Vascular, Inc.

Co-Founder, Chief Executive Officer and Director
Co-Founder, President and Director
Senior Vice President of Manufacturing & Operations
Vice President of Engineering
Director of Regulatory and Quality Affairs
Compensation as of Fiscal Year 2016.

Velano Vascular, Inc. Key Developments

Jacqueline G. Somerville to Join Velano Vascular's Advisory Board

Velano Vascular announced that Jacqueline G. Somerville will join the company's Advisory Board. A progressive nursing and healthcare veteran with 30 years of experience building and leading exceptional care delivery models, Somerville will help realize a more human-centered blood collection and vascular access experience for both patients and practitioners. Somerville is currently a Faculty Associate with the Watson Caring Science Institute and Visiting Scholar at Boston College William Connell School of Nursing. She has served patients, families and inter professional staff in a variety of roles, including Chief Nursing Officer and Senior Vice President Patient Care Services at Brigham and Women's Hospital, Associate Chief Nurse at Massachusetts General Hospital, Interim Chief Nursing Officer and Vice President Patient Care Services and Director of Preoperative Nursing at Beth Israel Deaconess Medical Center, Senior Consultant for the Center for Case Management, and Vice Chair for Surgical Nursing at New England Medical Center.

Velano Vascular Receives U.S. Food and Drug Administration Clearance for PIVO

Velano Vascular announced that it has received U.S. Food and Drug Administration clearance for PIVO, its innovative needle-free vascular access device that seeks to improve the blood draw experience for patients while reducing risk to both patients and practitioners. Based on significant usage and input from practitioners, the new, improved device is designed for ease-of-use and high volume manufacturing. The deliberate and thoughtful design inputs for the next generation of PIVO reflect company commitment to rapid product development cycles informed by real world experience in the country's health systems. PIVO is a single-use, disposable device that enables consistent, high quality blood samples from indwelling peripheral IV lines, allowing hospitals to reduce reliance on repeated needle sticks and central line access for blood collection. In addition to seeking a more compassionate care experience for patients, a safer environment for practitioners, and a more financially responsible alternative for health systems, PIVO aims to equip hospitals to better serve the increasing population of DVA (Difficult Venous Access) patients. PIVO is currently in use at multiple health systems nationwide and will be available more broadly in 2017 following this FDA-clearance for the second generation PIVO solution. Frost & Sullivan awarded PIVO its New Product Innovation Award for Vascular Access in 2016.

University Hospitals Case Medical Center Taps Velano Vascular Technology for Needleless Venous Blood Collection

University Hospitals (UH) announced a collaboration with Velano Vascular to use its PIVO needleless device for painless, high quality inpatient venous blood draws. The new device's breakthrough approach to peripheral intravenous catheter (PIV) blood draws will be launched initially at UH Case Medical Center in the Telemetry and Cardiac Intensive Care units, representing the first major U.S. academic medical center to commercially adopt Velano's innovation with the aim to establish a new standard of care. The FDA-approved PIVO innovation is a single-use, disposable device that expands the use of peripheral IV lines for frequent, high quality and needle-free blood draws. By attaching PIVO to a patient's IV catheter, practitioners can collect blood via a tube which is advanced through the IV. This new blood collection practice aims to reduce hospitals' reliance on repeat needle sticks and central line blood draws to provide a more compassionate care experience for hospital patients, a safer environment for caregivers, and a more financially responsible alternative for health systems.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Private Placement
March 7, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Velano Vascular, Inc., please visit www.velanovascular.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.